Literature DB >> 4201667

Inhibition of leucocyte migration by tumour-associated antigens of the colon and rectum.

P J Guillou, G R Giles.   

Abstract

The test of leucocyte migration inhibition has been used to detect lymphocyte sensitization to tumour-associated antigens of the colon and rectum. The procedure for the isolation of antigens from colorectal adenocarcinomata and normal colonic mucosa is described. The circulating lymphocytes of 22 patients suffering from colorectal adenocarcinomata of various stages have been examined and compared with the results obtained for identical studies performed on the peripheral lymphocytes of 15 control subjects. Sensitization of lymphocytes to tumour antigen was demonstrated in 15 of the 22 patients when culture was performed in homologous AB serum. Of these 15 patients only six showed inhibition of leucocyte migration in the presence of tumour extract when culture was performed in autologous serum. These observations would suggest the presence of factors in the serum of such patients which may prevent the expression of cellular immunity to tumour antigens.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4201667      PMCID: PMC1412774          DOI: 10.1136/gut.14.9.733

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Cellular and humoral immunity to different types of human neoplasms.

Authors:  I Hellström; K E Hellström; G E Pierce; J P Yang
Journal:  Nature       Date:  1968-12-28       Impact factor: 49.962

2.  Effect of autologous mammary tumour extracts on human leukocyte migration in vitro.

Authors:  V Andersen; O Bjerrum; G Bendixen; T Schiodt; I Dissing
Journal:  Int J Cancer       Date:  1970-05-15       Impact factor: 7.396

3.  'Lymphokines': molecular mediators of cellular immune responses in animals and man.

Authors:  D C Dumonde
Journal:  Proc R Soc Med       Date:  1970-09

4.  Blocking effect of serum from tumor-bearing animals on macrophage migration inhibition with tumor antigens.

Authors:  W J Halliday
Journal:  J Immunol       Date:  1971-03       Impact factor: 5.422

5.  Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms.

Authors:  I Hellström; H O Sjögren; G Warner; K E Hellström
Journal:  Int J Cancer       Date:  1971-03-15       Impact factor: 7.396

6.  Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma.

Authors:  G A Currie; F Lejeune; G H Fairley
Journal:  Br Med J       Date:  1971-05-08

7.  Inhibition of migration of human autogenous and allogeneic leukocytes by extracts of patients' cancers.

Authors:  W H Wolberg
Journal:  Cancer Res       Date:  1971-06       Impact factor: 12.701

8.  Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens.

Authors:  I Hellström; K E Hellström; C A Evans; G H Heppner; G E Pierce; J P Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1969-02       Impact factor: 11.205

9.  Studies of colonic carcinoma antigens.

Authors:  M S Kleinman; L Harwell; M D Turner
Journal:  Gut       Date:  1971-01       Impact factor: 23.059

10.  Specific carcinoembryonic antigens of the human digestive system.

Authors:  P Gold; S O Freedman
Journal:  J Exp Med       Date:  1965-09-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Large bowel cancer: causation and management.

Authors:  M B McIllmurray; M J Langman
Journal:  Gut       Date:  1975-10       Impact factor: 23.059

2.  A study of lymph nodes draining colorectal cancer using a two-stage inhibition of leucocyte migration technique.

Authors:  P J Guillou; T G Brennan; G R Giles
Journal:  Gut       Date:  1975-04       Impact factor: 23.059

3.  [Carcinofetal antigens. III. Further carcinofetal antigens (author's transl)].

Authors:  R Lamerz; A Fateh-Moghadam
Journal:  Klin Wochenschr       Date:  1975-05-01

4.  Survival and the immune response in patients with carcinoma of the colorectum.

Authors:  A K House; A G Watt
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

Review 5.  Tumour immunology and the gut.

Authors:  K C Calman
Journal:  Gut       Date:  1975-06       Impact factor: 23.059

6.  Migration inhibition with various cell fractions in human colorectal cancer.

Authors:  P R Armitstead; G Gowland
Journal:  Gut       Date:  1975-12       Impact factor: 23.059

7.  Lymphokine activated killer (LAK) cells in patients with gastrointestinal cancer.

Authors:  J R Monson; C W Ramsden; G R Giles; T G Brennan; P J Guillou
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

Review 8.  Adjuvant treatment of colorectal cancer. Current status and concepts.

Authors:  U F Metzger; B C Ghosh; D L Kisner
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

9.  Human intracranial tumors: effect of autologous serum addition on leucocyte migration inhibition.

Authors:  D K Böker
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

10.  The leucocyte adherence inhibtion test in cancer of the large bowel.

Authors:  P R Armitstead; G Gowland
Journal:  Br J Cancer       Date:  1975-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.